Jeil Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Jeil Pharmaceutical Co Ltd cash flow reinvestment rate. Jeil Pharmaceutical Co Ltd (271980) has a Cash Flow Reinvestment Rate of 5.76x as of December 2025, reinvesting ₩3.06 Billion (capex ₩2.23 Billion plus investments ₩831.46 Million) from operating cash flow of ₩532.03 Million. Explore 271980 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Jeil Pharmaceutical Co Ltd (2018–2024)
Cash flow reinvestment rate of Jeil Pharmaceutical Co Ltd from 2018 to 2024. Historical reinvestment intensity for Jeil Pharmaceutical Co Ltd across 4 annual periods. Explore Jeil Pharmaceutical Co Ltd (271980) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Jeil Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2018–2024)
Jeil Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2018 to 2024. Year-by-year capital reinvestment analysis for Jeil Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Jeil Pharmaceutical Co Ltd generate cash.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.47x | ₩7.93 Billion | ₩3.21 Billion | ₩6.61 Billion | ▲ +661.2% |
| 2021 | 0.32x | ₩6.19 Billion | ₩19.10 Billion | ₩5.34 Billion | ▲ +638.5% |
| 2019 | 0.04x | ₩1.27 Billion | ₩28.96 Billion | ₩1.09 Billion | ▼ -95.5% |
| 2018 | 0.96x | ₩20.69 Billion | ₩21.45 Billion | ₩10.29 Billion | — |